• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估柔性构象互补性:解释和诱导蛋白酪氨酸磷酸酶 1B 配体选择性的新机会。

Assessment of Flexible Shape Complementarity: New Opportunities to Explain and Induce Selectivity in Ligands of Protein Tyrosine Phosphatase 1B.

机构信息

Molecular Design Lab, Pharmaceutical & Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, Berlin, 14195, Germany.

出版信息

Mol Inform. 2019 May;38(5):e1800141. doi: 10.1002/minf.201800141. Epub 2019 Feb 6.

DOI:10.1002/minf.201800141
PMID:30725529
Abstract

For drug design projects it is essential to rationally induce and explain selectivity. In this context shape complementarity as well as protein and ligand flexibility represent important factors. Currently available tools for the analysis of protein-ligand interactions focus mainly on electrostatic complementarity and/or static structures. Here we address the shortcomings of available methods by presenting two new tools: The first one can be used to assess steric complementarity in flexible protein-ligand complexes in order to explain selectivity of known ligands. It further allows to determine ligand atoms with especially good or bad shape-fit which can be of use in lead optimization projects. The second tool was designed to detect differences in protein flexibility in similar proteins along with their exploitation for virtual screening. Both tools yield interesting results when applied to data of protein tyrosine phosphatase 1B (PTP1B): The case of PTP1B has proven especially difficult in terms of selectivity, due to a closely related phosphatase connected to severe undesired effects. With our tool for steric complementarity assessment we were able to explain previously undisclosed causes of moderate selectivity of selected PTP1B ligands. The second tool allowed us to find differences of flexibility in the two highly similar proteins and give directions for exploitation in virtual screening.

摘要

对于药物设计项目来说,合理地诱导和解释选择性是至关重要的。在这方面,形状互补以及蛋白质和配体的柔性是重要的因素。目前用于分析蛋白质-配体相互作用的工具主要集中在静电互补和/或静态结构上。在这里,我们通过提出两个新的工具来解决现有方法的缺点:第一个工具可用于评估柔性蛋白质-配体复合物中的空间互补性,以解释已知配体的选择性。它还可以确定配体原子的形状拟合特别好或特别差的原子,这在先导优化项目中可能会有用。第二个工具旨在检测相似蛋白质中蛋白质柔性的差异,并将其用于虚拟筛选。当将这两个工具应用于蛋白酪氨酸磷酸酶 1B(PTP1B)的数据时,它们都产生了有趣的结果:由于与严重不良反应相关的密切相关的磷酸酶,PTP1B 的选择性问题尤其难以解决。使用我们的空间互补性评估工具,我们能够解释先前未公开的选定 PTP1B 配体中度选择性的原因。第二个工具使我们能够发现两个高度相似的蛋白质之间的灵活性差异,并为虚拟筛选中的利用提供方向。

相似文献

1
Assessment of Flexible Shape Complementarity: New Opportunities to Explain and Induce Selectivity in Ligands of Protein Tyrosine Phosphatase 1B.评估柔性构象互补性:解释和诱导蛋白酪氨酸磷酸酶 1B 配体选择性的新机会。
Mol Inform. 2019 May;38(5):e1800141. doi: 10.1002/minf.201800141. Epub 2019 Feb 6.
2
Combined Ligand- and Receptor-Based Virtual Screening Methodology to Identify Structurally Diverse Protein Tyrosine Phosphatase 1B Inhibitors.基于配体和受体的联合虚拟筛选方法鉴定结构多样的蛋白酪氨酸磷酸酶 1B 抑制剂。
ChemMedChem. 2018 Sep 19;13(18):1939-1948. doi: 10.1002/cmdc.201800267. Epub 2018 Aug 23.
3
Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.基于结构的虚拟筛选方法以鉴定新型蛋白酪氨酸磷酸酶1B(PTP1B)抑制剂类别
Eur J Med Chem. 2009 Aug;44(8):3280-4. doi: 10.1016/j.ejmech.2009.02.011. Epub 2009 Feb 20.
4
Virtual Screening of Novel and Selective Inhibitors of Protein Tyrosine Phosphatase 1B over T-Cell Protein Tyrosine Phosphatase Using a Bidentate Inhibition Strategy.使用双齿抑制策略对 T 细胞蛋白酪氨酸磷酸酶进行新型和选择性蛋白酪氨酸磷酸酶 1B 抑制剂的虚拟筛选。
J Chem Inf Model. 2018 Apr 23;58(4):837-847. doi: 10.1021/acs.jcim.8b00040. Epub 2018 Apr 5.
5
Rationalizing protein-ligand interactions for PTP1B inhibitors using computational methods.运用计算方法合理优化蛋白-配体相互作用以研发 PTP1B 抑制剂。
Chem Biol Drug Des. 2009 Dec;74(6):582-95. doi: 10.1111/j.1747-0285.2009.00894.x. Epub 2009 Oct 12.
6
Discovery and evaluation of the hybrid of bromophenol and saccharide as potent and selective protein tyrosine phosphatase 1B inhibitors.发现并评价溴酚与糖的混合物作为有效和选择性的蛋白酪氨酸磷酸酶 1B 抑制剂。
Eur J Med Chem. 2017 Jul 7;134:24-33. doi: 10.1016/j.ejmech.2017.04.004. Epub 2017 Apr 4.
7
Studies of the mechanism of selectivity of protein tyrosine phosphatase 1B (PTP1B) bidentate inhibitors using molecular dynamics simulations and free energy calculations.利用分子动力学模拟和自由能计算研究蛋白酪氨酸磷酸酶1B(PTP1B)双齿抑制剂的选择性机制。
J Chem Inf Model. 2008 Oct;48(10):2030-41. doi: 10.1021/ci800104s. Epub 2008 Oct 3.
8
Design, synthesis of novel azolyl flavonoids and their protein tyrosine Phosphatase-1B inhibitory activities.设计、合成新型唑基黄酮类化合物及其蛋白酪氨酸磷酸酶-1B 抑制活性。
Bioorg Chem. 2018 Oct;80:195-203. doi: 10.1016/j.bioorg.2018.06.008. Epub 2018 Jun 5.
9
Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors.针对糖尿病肥胖的治疗:苯磺酰胺衍生物作为新型 PTP-1B 抑制剂的合理设计、合成与生物评价。
Bioorg Chem. 2019 May;86:322-338. doi: 10.1016/j.bioorg.2019.01.052. Epub 2019 Jan 31.
10
Quantitative structure-activity relationship (QSAR) and design of novel ligands that demonstrate high potency and target selectivity as protein tyrosine phosphatase 1B (PTP 1B) inhibitors as an effective strategy used to model anti-diabetic agents.定量构效关系(QSAR)以及新型配体的设计,这些新型配体作为蛋白酪氨酸磷酸酶1B(PTP 1B)抑制剂表现出高效力和靶点选择性,是用于模拟抗糖尿病药物的有效策略。
J Recept Signal Transduct Res. 2020 Dec;40(6):501-520. doi: 10.1080/10799893.2020.1759092. Epub 2020 May 12.